Conditional corticotropin-releasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleep

Molecular Psychiatry

Volumn 15, Issue 2, 2010, Pages 154-165

  Kimura, M ^a   Muller Preuss P ^a   Lu, A ^a,c   Wiesner, E ^a   Flachskamm, C ^a   Wurst, W ^a,b   Holsboer, F ^a   Deussing, J M ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Corticotropin releasing hormone; CRHR1 antagonist; Depression; Hypothalamic pituitary adrenocortical axis; REM sleep; Sleep deprivation

Indexed keywords

8 (2,4 DICHLOROPHENYL) 4 [2 METHOXY 1 (METHOXYMETHYL)ETHYLAMINO] 2,7 DIMETHYLPYRAZOLO[1,5 A][1,3,5]TRIAZINE; CORTICOTROPIN RELEASING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; FOREBRAIN; GENOTYPE; HORMONE RELEASE; LIGHT; LIMBIC SYSTEM; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REM SLEEP; SLEEP DEPRIVATION; STRESS; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; FOURIER ANALYSIS; GENE EXPRESSION REGULATION; INTERMEDIATE FILAMENT PROTEINS; METHYLCELLULOSE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; PROSENCEPHALON; PYRAZOLES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SLEEP DEPRIVATION; SLEEP, REM; TIME FACTORS; TRIAZINES;

EID: 75549091827     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2009.46     Document Type: Article

References (65)

1. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of cortico-tropin and b-endorphin. Science 1981; 213: 1394-1397.
2. Dunn AJ, Berridge CW. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev 1990; 15: 71-100.
3. Habib KE, Gold PW, Chrousos GP. Neuroendocrinology of stress. Endocrinol Metab Clin North Am 2001; 30: 695-728.
4. Friess E, Wiedemann K, Steiger A, Holsboer F. The hypothalamic-pituitary- adrenocortical system and sleep in man. Adv Neuroim-munol 1995; 5: 111-125.
5. Buckley TM, Schatzberg AF. On the interactions of the hypotha-lamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 2005; 90: 3106-3114.
6. Steiger A. Neurochemical regulation of sleep. J Psychiatr Res 2007; 41: 537-552.
7. Holsboer F, von Bardeleben U, Steiger A. Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. Neurendocrinology 1988; 48: 32-38.
8. Born J, Spath-Schwalbe E, Schwakenhofer H, Kern W, Fehm HL. Influences of corticotropin-releasing hormone, adrenocorticotro-pin, and cortisol on sleep in normal man. J Clin Endocrinol Metab 1989; 68: 904-911.
9. Ehlers CL, Reed TK, Henriksen SJ. Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 1986; 42: 467-474.
10. Chang FC, Opp MR. Corticotropin-releasing hormone (CRH) as a regulator of waking. Neurosci Biobehav Rev 2001; 25: 445-453.
11. Chastrette N, Clement HW, Prevautel H, Cespuglio R. Proopiome-lanocortin components: differential sleep-waking regulation? In: Inoué S, Schneider-Helmert D (eds). Sleep Peptides: Basic and Clinical Approaches. Springer-Verlag: Tokyo/Berlin, 1988, pp 27-52.
12. Bradbury MJ, Dement WC, Edgar DM. Effects of adrenalectomy and subsequent corticosterone replacement on rat sleep state and EEG power spectra. Am J Physiol 1998; 275: R555-R565.
13. Lu A, Steiner MA, Whittle N, Vogl AM, Walser SM, Ableitner M et al. Conditional mouse mutants highlight mechanisms of cortico-tropin-releasing hormone effects on stress coping behavior. Mol Psychiatry 2008; 13: 1028-1042.
14. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 1999; 23: 99-103.
15. Minichiello L, Korte M, Wolfer D, Kuhn R, Unsicker K, Cestari V et al. Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 1999; 24: 401-414.
16. Louis RP, Lee J, Stephenson R. Design and validation of a computer-based sleep-scoring algorithm. J Neurosci Meth 2004; 133: 71-80.
17. Maciag CM, Dent G, Gilligan P, He L, Dowling K, Ko T et al. Effects of a non-peptide CRF antagonist (DMP696) on the behavioral and endocrine sequelae of maternal separation. Neuropsychopharma-cology 2002; 26: 574-582.
18. Borbely AA. A two process model of sleep regulation. Hum Neurobiol 1982; 1: 195-206.
19. Franken P, Chollet D, Tafti M. The homeostatic regulation of sleep need is under genetic control. J Neurosci 2001; 21: 2610-2621.
20. Marrosu F, Gessa GL, Giagheddu M, Fratta W. Corticotropin-releasing factor (CRF) increases paradoxical sleep (PS) rebound in PS-deprived rats. Brain Res 1990; 515: 315-318.
21. Groenink L, Dirks A, Verdouw PM, Schipholt M, Veening JG, van der Gugten J et al. HPA axis dysregulation in mice over-expressing corticotropin releasing hormone. Biol Psychiatry 2002; 51: 875-881.
22. Stenzel-Poore MP, Cameron VA, Vaughan J, Sawchenko PE, Vale W. Development of Cushing's Syndrome in corticotropin-releasing factor transgenic mice. Endocrinology 1992; 130: 3378-3386.
23. Gonzalez MM, Valatx JL. Effect of intracerebroventricular administration of alpha-helical CRH (9-41) on the sleep/waking cycle in rats under normal conditions or after subjection to an acute stressful stimulus. J Sleep Res 1997; 6: 164-170.
24. Chang FC, Opp MR. Role of corticotropin-releasing hormone in stressor-induced alterations of sleep in rat. Am J Physiol 2002; 283: R400-R407.
25. Held K, Antonijevic I, Murck H, Künzel H, Steiger A. Alpha-helical CRH exerts CRH agonistic effects on sleep-endocrine activity in humans. Neuropsychobiology 2005; 52: 62-67.
26. De Kloet ER, Joëls M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005; 6: 463-475.
27. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 1999; 160: 1-12.
28. Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res 1999; 33: 181-214.
29. Benca RM, Obermeyer WH, Thisted RA, Gillin JC. Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry 1992; 49: 651-668.
30. Thase ME, Kupfer DJ, Fasiczka AJ, Buysse DJ, Simons AD, Frank E. Identifying an abnormal electroencephalographic sleep profile to characterize major depressive disorder. Biol Psychiatry 1997; 41: 964-973.
31. Gray TS, Bingaman EW. The amygdala: corticotropin-releasing factor, steroids, and stress. Crit Rev Neurobiol 1996; 10: 155-168.
32. Amaral DG, Price JL, Pitkänen A, Carmichael ST. Anatomical organization of the primate amygdaloid complex. In: Aggleton JP (ed) The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. Wiley-Liss: New York, 1992; pp: 1-66.
33. Valentino RJ, Page ME, Luppi PH, Zhu Y, Van Bockstaele E, Aston-Jones G. Evidence for widespread afferents to Barrington's nucleus, a brainstem region rich in corticotropin-releasing hormone neurons. Neuroscience 1994; 62: 125-143.
34. Quattrochi J, Datta S, Hobson JA. Cholinergic and non-cholinergic afferents of the caudolateral parabrachial nucleus: a role in the long-term enhancement of rapid eye movement sleep. Neu-roscience 1998; 83: 1123-1136.
35. Lai YY, Siegel JM. Corticotropin-releasing factor mediated muscle atonia in pons and medulla. Brain Res 1992; 575: 63-68.
36. Smith CT, Miskiman DE. Increases in paradoxical sleep as a result of amygdaloid stimulation. Physiol Behav 1975; 15: 17-19.
37. Calvo JM, Simón-Arceo K, Fernández-Mas R. Prolonged enhancement of REM sleep produced by carbachol microinjection into the amygdala. Neuroreport 1996; 7: 577-580.
38. Wiersma A, Konsman JP, Knollema S, Bohus B, Koolhaas JM. Differential effects of CRH infusion into the central nucleus of the amygdala in the Roman high-avoidance and low-avoidance rats. Psychoneuroendocrinology 1998; 23: 261-274.
39. Benca RM, Obermeyer WH, Shelton SE, Droster J, Kalin NH. Effects of amygdala lesions on sleep in rhesus monkeys. Brain Res 2000; 879: 130-138.
40. Maquet P, Peters J, Aerts J, Delfiore G, Degueldre C, Luxen A et al. Functional neuroanatomy of human rapid-eye-movement sleep and dreaming. Nature 1996; 383: 163-166.
41. Nofzinger E, Mintun M, Wiseman M, Kupfer D, Moore R. Forebrain activation in REM sleep: an FDG PET study. Brain Res 1997; 770: 192-201.
42. Moga MM, Gray T. Evidence for corticotropin-releasing factor, neurotensin, and somatostatin in the neural pathway from the central nucleus of the amygdala to the parabrachial nucleus. J Comp Neurol 1985; 241: 275-284.
43. Romanowski C, Fenzl T, Flachskamm C, Deussing JM, Kimura M. CRH-R1 is involved in effects of CRH on NREM, but not REM, sleep suppression. Sleep Biol Rhythms 2007; 5(suppl 1): A53.
44. Grammatopoulos DK, Crousos GP. Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab 2002; 13: 436-444.
45. Marinesco S, Bonnet S, Cespuglio R. Influence of stress duration on the sleep rebound induced by immoblization in the rat: a possible role for corticosterone. Neuroscience 1999; 92: 921-933.
46. Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984; 226: 1342-1344.
47. Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJ, Swaab DF. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 1995; 152: 1372-1376.
48. Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P et al. Pronounced and sustained central hyperadrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin- releasing hormone. Proc Natl Acad Sci USA 2000; 97: 325-330.
49. Henn FA, Vollmayr B. Stress models of depression: forming genetically vulnerable strains. Neurosci Biobehav Rev 2005; 29: 799-804.
50. Zobel AW, Nickel T, Künzel HE, Ackl N, Sonntag A, Ising M et al. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psychiatr Res 2000; 34: 171-181.
51. Dugovic C, Maccari S, Weibel L, Turek FW, Van Reeth O. High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations. J Neurosci 1999; 19: 8656-8664.
52. Dugovic C, Solberg LC, Redei E, Van Reeth O, Turek FW. Sleep in the Wister-Kyoto rat, a putative genetic animal model for depression. Neuroreport 2000; 11: 627-631.
53. El Yacoubi M, Bouali S, Popa D, Naudon L, Leroux-Nicollet I, Hamon M et al. Behavioral, neurochemical, and electrophysiolo-gical characterization of a genetic mouse model of depression. Proc Natl Acad Sci USA 2003; 100: 6227-6232.
54. Overstreet DH, Friedman E, Mathé AA, Yadid G. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 2005; 29: 739-759.
55. Touma C, Fenzl T, Ruschel J, Palme R, Holsboer F, Kimura M et al. Rhythmicity in mice selected for extremes in stress reactivity: behavioural, endocrine and sleep changes resembling endophe-notypes of major depression. PLoS ONE 4: e4325.
56. Sanford LD, Yang L, Wellman LL, Dong E, Tang X. Mouse strain differences in the effects of corticotropin-releasing hormone (CRH) on sleep and wakefulness. Brain Res 2008; 1190: 94-104.
57. Gonzalez MM, Valatx JL. Involvement of stress in the sleep rebound mechanism induced by sleep deprivation in the rat: use of alpha-helical CRH (9-41). Behav Pharmacol 1998; 9: 655-662.
58. Feng P, Liu X, Vurbic D, Fan H, Wang S. Neonatal REM sleep is regulated by corticotropin-releasing factor. Behav Brain Res 2007; 182: 95-102.
59. Rampin C, Cespuglio R, Chastrette N, Jouvet M. Immobilisation stress induces a paradoxical sleep rebound in rat. Neurosci Lett 1991; 126: 113-118.
60. Bouyer JJ, Vallée M, Deminière JM, Le Moal M, Mayo W. Reaction of sleep-wakefulness cycle to stress is related to differences in hypothalamo-pituitary-adrenal axis reactivity in rat. Brain Res 1998; 804: 114-124.
61. Koehl M, Bouyer JJ, Darnaudéry M, Le Moal M, Mayo W. The effect of restraint stress on paradoxical sleep is influenced by the circadian time. Brain Res 2002; 937: 45-50.
62. Pawlyk AC, Sanford LD, Brennan FX, Morrison AR, Ross RJ. Corticotropin-releasing factor microinjection into the central nucleus of the amygdala alters REM sleep. Pharmacol Rep 2006; 58: 125-130.
63. McCarley RW. REM sleep and depression: common neuro-biological control mechanisms. Am J Psychiatry 1982; 139: 565-570.
64. Gottesmann C, Gottesman I. The neurobiological characteristics of rapid eye movement (REM) sleep are candidate endophenotypes of depression, schizophrenia, mental retardation and dementia. Prog Neurobiol 2007; 81: 237-250.
65. Modell S, Ising M, Holsboer F, Lauer CJ. The Munich vulnerability study on affective disorders: premorbid polysomnographic profile of affected high-risk probands. Biol Psychiatry 2005; 58: 694-699. (Pubitemid 41547236)